These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21525440)

  • 1. Diabetes, hypertension, and outcome studies: overview 2010.
    Nilsson PM; Cederholm J
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S109-13. PubMed ID: 21525440
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing cardiovascular disease in hypertensive patients with type 2 diabetes: is there a superior antihypertensive therapy?
    Tuomilehto J
    J Hypertens; 2000 Nov; 18(11):1553-6. PubMed ID: 11081766
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with beta-blockers for the primary prevention of the cardiovascular complications of hypertension.
    Staessen JA; Wang JG; Birkenhäger WH; Fagard R
    Eur Heart J; 1999 Jan; 20(1):11-24. PubMed ID: 10075137
    [No Abstract]   [Full Text] [Related]  

  • 4. [Type 2 diabetes. Routine ACE inhibitors?].
    Hönl SB
    Med Monatsschr Pharm; 2008 Apr; 31(4):149-50. PubMed ID: 18497249
    [No Abstract]   [Full Text] [Related]  

  • 5. Sounding board. Should mild hypertension be treated?
    Freis ED
    N Engl J Med; 1982 Jul; 307(5):306-9. PubMed ID: 7045669
    [No Abstract]   [Full Text] [Related]  

  • 6. An overview of the meta-analyses of the hypertension treatment trials.
    Moser M; Hebert P; Hennekens CH
    Arch Intern Med; 1991 Jul; 151(7):1277-9. PubMed ID: 1829605
    [No Abstract]   [Full Text] [Related]  

  • 7. Intensive blood pressure/glucose control in type 2 diabetes: why is it so difficult to decrease coronary heart disease?
    Reaven GM
    J Hum Hypertens; 1999 Apr; 13 Suppl 2():S19-23; discussion S25-8. PubMed ID: 10335853
    [No Abstract]   [Full Text] [Related]  

  • 8. Update on Hypertension Management: treatment of hypertension in patients with type 2 diabetes mellitus.
    Nilsson PM; Cifkova R; Kjeldsen SE
    J Hypertens; 2006 Jan; 24(1):208-10. PubMed ID: 16331123
    [No Abstract]   [Full Text] [Related]  

  • 9. How safe is carvedilol in NIDDM patients with hypertension?
    Choudhury D; Misra A
    Natl Med J India; 1998; 11(3):130-1. PubMed ID: 9707705
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertension in non-insulin dependent diabetes mellitus and its management.
    Feher MD
    Postgrad Med J; 1991 Oct; 67(792):938-46. PubMed ID: 1758808
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertension and coronary risk: possible adverse effects of antihypertensive drugs.
    Robertson JI
    Am Heart J; 1987 Oct; 114(4 Pt 2):1051-4. PubMed ID: 3310571
    [No Abstract]   [Full Text] [Related]  

  • 12. [ALLHAT].
    Ando K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():402-7. PubMed ID: 16981570
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antihypertensive treatment in the type 2 diabetic].
    Fournier A
    Nephrologie; 2000; 21(4):203-4. PubMed ID: 10976435
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ALLHAT trial--antithesis to the overuse of vasodilating antihypertensive drugs].
    Kuwajima I
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():648-53. PubMed ID: 15171450
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypertension: a review and rationale of treatment.
    Copley JB; Rosario R
    Dis Mon; 2005; 51(10-11):548-614. PubMed ID: 16360376
    [No Abstract]   [Full Text] [Related]  

  • 17. [Choice of hypertensive agents for patients with diabetes].
    Aursnes I
    Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3294-5. PubMed ID: 11187173
    [No Abstract]   [Full Text] [Related]  

  • 18. Do pharmacologic differences among antihypertensive agents point to clinical benefits?
    Meredith P
    Am J Cardiol; 1999 Nov; 84(10A):22S-27S. PubMed ID: 10588091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
    Coca A; Ruilope LM
    Med Clin (Barc); 2000 Jul; 115(5):178-80. PubMed ID: 10996874
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents.
    Sarafidis PA; Bakris GL
    J Hypertens; 2007 Jan; 25(1):249-52; author reply 252-3. PubMed ID: 17143201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.